CIK: 0001540358 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $1,394,891 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FIG | FIGMA INC | 16,246,129 | $842,687 | 60.4% | $68.66 | 0.0% | CLASS A COM STK | 316841105 |
| META | META PLATFORMS INC | 212,531 | $156,079 | 11.2% | $743.23 | 0.0% | CL A | 30303M102 |
| RVMD | REVOLUTION MEDICINES INC | 2,748,523 | $128,356 | 9.2% | $24.03 | +62.9% | COM | 76155X100 |
| OMDA | OMADA HEALTH INC | 4,614,574 | $102,028 | 7.3% | $17.31 | +18.3% | COM | 68170A108 |
| XYZ | BLOCK INC | 1,016,697 | $73,477 | 5.3% | $56.54 | +32.4% | CL A | 852234103 |
| MAZE | MAZE THERAPEUTICS INC | 1,702,225 | $44,139 | 3.2% | $12.04 | +40.2% | COM | 578784100 |
| BIOA | BIOAGE LABS INC | 3,233,170 | $19,011 | 1.4% | $19.85 | -76.4% | COM | 09077V100 |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | 17,653,917 | $14,916 | 1.1% | $2.86 | -74.3% | COM | 63909J108 |
| CAMP | CAMP4 THERAPEUTICS CORP | 2,125,339 | $6,376 | 0.5% | $8.22 | -77.5% | COM | 13463J101 |
| ERAS | ERASCA INC | 2,862,500 | $6,240 | 0.4% | $2.11 | -24.6% | COM | 29479A108 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 108,568 | $1,583 | 0.1% | $10.02 | +19.4% | CL A NEW | 37611X209 |